MEDICINES CONTROL COUNCIL
|
|
|
- Hollie McCormick
- 5 years ago
- Views:
Transcription
1 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10 INGELHEIM A39/23/0594 FRESENIUS KABI SOUTH AFRICA VETMEDIN 1,25 mg VETMEDIN 5 mg AMINOVEN 3,5% GE PIMOBENDAN 1,25 mg PIMOBENDAN 5,0 mg Each 1 000,0 ml solution TOTAL AMINO ACIDS 35,0 g L-isoleucine 1,75 g L-leucine 2,59 g L-methionine 1,505 g L-lysine 2,31 g L-phenylalanine 1,785 g L-threonine 1,54 g L-tryptophan 0,70 g L-valine 2,17 g L-arginine 4,20 g L-histidine 1,05 g L-alanine 4,90 g Glycine 3,85 g L-proline 3,92 g L-serine 2,275 g Taurine 0,35 g Sodium Chloride 1,169 g Calcium Chloride 0,222 g Magnesium Chloride 0,286 g Zinc Chloride 0,00545 g Potassium Hydroxide 1,98 g Sodium glycerophosphate 3,241 g Glucose Monohydrate 55,0 g A40/11.4.3/0192 PHARMACARE LIMITED ALTOSEC 40 mg/10 ml Each vial OMEPRAZOLE 40,0 mg Notification of Jun10v1.doc July 2010 Page 1 of 5
2 A40/34/0431 PHARMACARE LIMITED ALTOSEC SOLVENT FOR INJECTABLE SOLUTION A40/7.1.3/0685 SPECPHARM SPEC CARVEDILOL 6,25 A40/7.1.3/0686 SPECPHARM SPEC CARVEDILOL 12,5 Each ampoule WATER FOR INJECTIONS 10,0 ml CARVEDILOL 6,25 mg CARVEDILOL 12,5 mg A40/7.1.3/0687 SPECPHARM SPEC CARVEDILOL 25 CARVEDILOL 25,0 mg A40/14.2/0698 BRISTOL-MYERS SQUIBB 41/8.1/0223 PHARMAFRICA (PTY) 41/7.3/0369 DR REDDY S LABORATORIES (PTY) 41/7.3/0370 DR REDDY S LABORATORIES (PTY) 41/21.2/0487 NOVARTIS SOUTH AFRICA 41/20.3/0719 SCHERING-PLOUGH 41/3.1/0996 STRIDES SA 41/3.1/0997 STRIDES SA 41/3.1/1085 STRIDES SA 42/5.8/0099 JOHNSON & JOHNSON 42/34/0514 SAFELINE 42/20.2.8/0538 AUROBIND PHARMA 42/20.2.8/0539 AUROBIND PHARMA 42/20.2.8/0540 AUROBIND PHARMA AQUACEL-AG WITH HYDROFIBER GOLDSHIELD TRANEXAMIC ACID 500 mg MEGAN 50 MEGAN 100 GALVUS 50 mg NOXAFIL 40 mg/ml KETOJECT 15 mg/1 ml KETOJECT 60 mg/2 ml KETOJECT 30 mg/1 ml SUDAFED PE SINUS DECONGESTANT SOLVENT FOR OMEPRAZOLE SAFELINE INJECTION 40 mg 50 mg 100 mg 200 mg Each 100,0 g of dressing SODIUM SILVER CARBOXYMETHYL- CELLULOSE 100,0 g TRANEXAMIC ACID 500,0 mg SUMATRIPTAN 50,0 mg SUMATRIPTAN 100,0 mg VILDAGLIPTIN 50,0 mg Each 1,0 ml suspension POSACONAZOLE 40,0 mg Each 1,0 ml solution TROMETHAMINE 15,0 mg Each 1,0 ml solution TROMETHAMINE 30,0 mg Each 1,0 ml solution TROMETHAMINE 30,0 mg PHENYLEPHRINE 10,0 mg Each vial WATER FOR INJECTION Each capsule EFAVIRENZ 50,0 mg Each capsule EFAVIRENZ 100,0 mg Each capsule EFAVIRENZ 200,0 mg Notification of Jun10v1.doc July 2010 Page 2 of 5
3 42/21.5.4/0581 GROUP LABORATORIES 42/21.5.4/0582 GROUP LABORATORIES 42/21.5.4/0583 GROUP LABORATORIES 42/21.5.4/0584 GROUP LABORATORIES 42/21.5.4/0585 GROUP LABORATORIES 42/21.5.4/0586 GROUP LABORATORIES 42/20.1.1/0636 RANBAXY (S.A.) (PTY) 42/20.1.1/0637 RANBAXY (S.A.) (PTY) 42/26/0758 TEVA 42/26/0759 TEVA FOXAIR 50/100 FOXAIR 50/250 FOXAIR 50/500 SALMEFLUT 50/100 SALMEFLUT 50/250 SALMEFLUT 50/500 BACQURE 500 CILAPEN 500 TEVA VINORELBINE 10 TEVA VINORELBINE 50 Each blister 100,0 µg Each blister 250,0 µg Each blister 500,0 µg Each blister 100,0 µg Each blister 250,0 µg Each blister 500,0 µg Each vial IMIPENEM 500,0 mg CILASTATIN SODIUM CILASTATIN 500,0 mg Each vial IMIPENEM 500,0 mg CILASTATIN SODIUM CILASTATIN 500,0 mg Each vial VINORELBINE TARTRATE VINORELBINE 10,0 mg Each vial VINORELBINE TARTRATE VINORELBINE 50,0 mg Notification of Jun10v1.doc July 2010 Page 3 of 5
4 42/20.2.8/0987 AUROBIND PHARMA ZYNOVIR ORAL SOLUTION 50 mg/5 ml Each 5,0 ml solution ZIDOVUDINE 50,0 mg 43/20.2.8/0181 PHARMACARE LIMITED ASPEN TENOFOVIR 43/11.3/0192 GROUP LABORATORIES 43/5.4.1/0216 ZYDUS HEALTHCARE SA 43/5.4.1/0217 ZYDUS HEALTHCARE SA 43/5.4.1/0218 ZYDUS HEALTHCARE SA 43/5.4.1/0219 ZYDUS HEALTHCARE SA 43/5.4.1/0220 ZYDUS HEALTHCARE SA 43/8.2/0242 ELI LILLY (S.A.) (PTY) 43/8.2/0243 ELI LILLY (S.A.) (PTY) 43/20.2.8/0287 AUROBINDO PHARMA 43/20.2.8/0356 ABBOTT LABORATORIES S.A. 43/20.2.8/0385 ADCOCK INGRAM LIMITED ALLI RESURE 0,25 RESURE 0,5 RESURE 1,0 RESURE 2,0 RESURE 5,0 EFIENT 5 mg EFIENT 10 mg BINDOPIN SUSPENSION 50 mg/5 ml ALUVIA 100/25 ABAVAID Each capsule ORLISTAT 60,0 mg RIPINIROLE 0,25 mg RIPINIROLE 0,5 mg RIPINIROLE 1,0 mg RIPINIROLE 2,0 mg RIPINIROLE 5,0 mg PRASUGREL PRASUGREL 5,0 mg PRASUGREL PRASUGREL 10,0 mg Each 5,0 ml suspension NEVIRAPINE 50,0 mg LOPINAVIR 100,0 mg RITONAVIR 25,0 mg ABACAVIR SULPHATE Notification of Jun10v1.doc July 2010 Page 4 of 5
5 43/20.2.8/0386 ADCOCK INGRAM LIMITED 43/30.2/0401 GLAXOSMITHKLINE ADCO ABACAVIR SYNFLORIX ABACAVIR SULPHATE Each 0,5 ml dose POLYSACCHARIDE FOR SEROTYPES: 1; 5; 6B; 7F; 9V; 14; 23F 1,0 µg 4; 18CV; 19F 3,0 µg 43/20.2.8/0724 PHARMACARE LIMITED ASPEN ABACAVIR /20.2.8/1102 PHARMACARE LIMITED AP LAMIVUDINE 150 mg 44/20.2.8/0086 AUROBIND PHARMA 44/20.2.8/0087 AUROBIND PHARMA 44/20.2.8/0344 RANBAXY (S.A.) (PTY) 44/20.2.8/0345 RANBAXY (S.A.) (PTY) 44/20.2.8/0445 CIPLA LIFE SCIENCES 44/20.2.8/0446 CIPLA MEDPRO (PTY) TYRICTEN 200/300 mg EMTRICITABINE/TENO FOVIR AURO 200/300 mg SONKE DIDANOSINE 250 SONKE DIDANOSINE 400 CIPLA TENOFOVIR/EMTRICIT ABINE DIDIVIR LAMIVUDINE 150,0 mg Each capsule DIDANOSINE 250,0 mg Each capsule DIDANOSINE 400,0 mg REGISTRAR OF MEDICINES MS MANDISA HELA Notification of Jun10v1.doc July 2010 Page 5 of 5
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 30/2.10/0392 TEVA TEVA BACLOFEN
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS
STANDARD 2.9.4 FORMULATED SUPPLEMENTARY SPORTS FOODS Purpose This Standard defines and regulates the composition and labelling of foods specially formulated to assist sports people in achieving specific
EUROPEAN MEDICINES AGENCY DECISION. of 2 October 2009
European Medicines Agency Doc. Ref. EMEA/610520/2009 P/191/2009 EUROPEAN MEDICINES AGENCY DECISION of 2 October 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for alanine,
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MSUD HCU Tyrosinaemia MMA/PA IVA (for PKU cooler see pages 11-13)
(for PKU see pages 11-13) + Description A food for special medical purposes. Cooler is a ready-to-drink protein substitute containing essential and non-essential amino acids (but excluding the offending
Vamin 18 EF QUALITATIVE AND QUANTITATIVE COMPOSITION
Title Page Information Dec. 2000 1 (7) Number Vamin 18 EF 121-01 1. NAME OF THE MEDICINAL PRODUCT Vamin 18 g N/l electrolyte-free infusion fluid, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1000
Full Report (All Nutrients) 01174, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D
National base for Standard Reference Release 28 slightly revised May, 206 Full Report (All s) 074, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D Report Date: February 23,
ssniff Complete feeds for rabbits and guinea pigs *
ssniff Complete feeds for rabbits and guinea pigs * Complete diets for all development and life stages Comparable to other animal species also for the breeding and rearing of guinea pigs and rabbits higher
Age-related reference ranges
Authoriser: Peter Beresford Page 1 of 6 Age-related reference ranges Alkaline Phosphatase (ALP) IU/L Both less than 14 days 90 273 Both 14 days
Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion
Package leaflet: Information for the user Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Read all of this leaflet carefully before you start using
Food for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria.
PKU Nutri 1 Energy Food for special medical purposes. For the dietary management of proven phenylketonuria (PKU) in infants from birth to 12 months and as a supplementary feed up to 3 years. An amino acid
2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY 3. COMPOSITION OF THE MEDICINAL PRODUCT ml of the solution for infusion contain:
Title Page Information June 1999 1 (5) Aminoven infant 10% 1. NAME OF THE MEDICINAL PRODUCT Aminoven infant 10% 2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY For sale in pharmacies only
EUROPEAN MEDICINES AGENCY DECISION. of 7 September 2009
European Medicines Agency Doc. Ref. EMEA/551360/2009 P/175/2009 EUROPEAN MEDICINES AGENCY DECISION of 7 September 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for
This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February
Amino Acid Analyzer AAA400
Amino Acid Analyzer AAA400 Determination of amino acid of hydrolyzates (food and feed) Column: LG ANB OSTION 3.6x340 12μm Eluents: sodium-citrate buffers, 0.2 M NaOH Aspartic Acid, Threonine, Serine, Glutamic
ANNEX. to the COMMISSION REGULATION (EU) /
EUROPEAN COMMISSION Brussels, XXX SANTE/12273/2015 ANNEX (POOL/E4/2015/12273/12273-EN ANNEX.doc) D043783/01 [ ](2016) XXX draft ANNEX 1 ANNEX to the COMMISSION REGULATION (EU) / amending Regulation (EU)
ssniff Complete feeds with low phytoestrogen content for rats and mice / nude rats and nude mice*
ssniff Complete feeds with low phytoestrogen content for rats and mice / nude rats and nude mice* Complete diets for all development and life stages has producing various low-phytoestrogen diets (free
Package leaflet: Information for the user. SmofKabiven emulsion for infusion
Package leaflet: Information for the user SmofKabiven emulsion for infusion Read all of this leaflet carefully before you start using this medicine because it contains important information for you. -
Product Information: Phenex -1
Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake
Council of the European Union Brussels, 12 May 2016 (OR. en)
Council of the European Union Brussels, 12 May 2016 (OR. en) 8540/16 ADD 1 REV 1 DENLEG 34 AGRI 222 SAN 162 COVER NOTE From: European Commission date of receipt: 10 May 2016 To: General Secretariat of
Product Information: Propimex -1
Product Information: Propimex -1 1 of 5 Nutrition support of infants and toddlers with propionic or methylmalonic acidemia. Methionine- and valine-free; low in isoleucine and threonine. Use under medical
Product Information: Tyrex -1
Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free
LAB#23: Biochemical Evidence of Evolution Name: Period Date :
LAB#23: Biochemical Evidence of Name: Period Date : Laboratory Experience #23 Bridge Worth 80 Lab Minutes If two organisms have similar portions of DNA (genes), these organisms will probably make similar
Product Information: Ketonex -1
Product Information: 1 of 5 Nutrition support of infants and toddlers with maple syrup urine disease (MSUD). Isoleucine-, leucine- and valine-free. Use under medical supervision. Branched-chain amino acid-free
1. Describe the relationship of dietary protein and the health of major body systems.
Food Explorations Lab I: The Building Blocks STUDENT LAB INVESTIGATIONS Name: Lab Overview In this investigation, you will be constructing animal and plant proteins using beads to represent the amino acids.
Amino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3
Fundamentals While their name implies that amino acids are compounds that contain an 2 group and a 2 group, these groups are actually present as 3 and 2 respectively. They are classified as α, β, γ, etc..
Package leaflet: Information for the user. StructoKabiven emulsion for infusion
Package leaflet: Information for the user emulsion for infusion Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet.
Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health
Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health INTRODUCTION: MicrobeBio Hydro Activator naturally occurring beneficial organisms, 100% organic proteins, and
Sesame seed powder * product is currently being developed. Chia powder * Product nr HP01 HP04 PU01 SS01 CH01 A01 FS01 FS02 P01 P02 R02
Minerals and approved health claims 2 servings of 20 gr/day RDI (EU) mg/ day Source of 15% RDI (mg) Rich in 30% RDI (mg) - Belgian origin Pumpkin Sesame product is currently being developed Chia might
Visual evaluation of early (~ 4-cell) mammalian embryos. How well does it predict subsequent viability? Marie-Noël Bruné Rossel APPENDICES
Visual evaluation of early (~ 4-cell) mammalian embryos. How well does it predict subsequent viability? Marie-Noël Bruné Rossel APPENDICES 1) Glossary (alphabetical) (From the Aberdeen Fertility Centre
WHO Global Price Reporting Mechanism the importance of data registration for the regulation of antiretrovirals (ARV) and access to treatment
WHO Global Price Reporting Mechanism the importance of data registration for the regulation of antiretrovirals (ARV) and access to treatment Boniface Dongmo Nguimfack HIV/Technology and Commodities 1 AMDS
0010 Amino Acids 40 Profile - Plasma
Accession #: Order #: G1234567 Date Collected: Date Received: 01/22/2013 Reference #: Patient: Date of Birth: 02/05/1962 Date of Report: Telephone: 7704464583 Ordering Physician: 1234 Main St. Anywhere,
Soy Protein. Muscle health benefits: for Sports Nutrition Recovery and during aging. May 9, Mark Cope, PhD
Soy Protein Muscle health benefits: for Sports Nutrition Recovery and during aging May 9, 2017 Mark Cope, PhD Blending Proteins to Provide Better Muscle Health Importance of Muscle Health The Benefits
Product Information: EleCare Jr
Product Information: EleCare Jr 1 of 5 A 30 Cal/fl oz, nutritionally complete amino acid-based medical food for children age 1 and older who cannot tolerate intact or hydrolyzed protein. EleCare Jr is
0010 Amino Acid Analysis - 40 Plasma
770.446.5483 770.441.2237 This report contains reference range adjustments from routine revalidation procedures. It also contains the following three upgrades: 1) The amino acids have been reorganized
Official Journal of the European Union
L 230/8 EN 25.8.2016 COMMISSION REGULATION (EU) 2016/1413 of 24 August 2016 amending Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods other than those referring
Lecture 3: 8/24. CHAPTER 3 Amino Acids
Lecture 3: 8/24 CHAPTER 3 Amino Acids 1 Chapter 3 Outline 2 Amino Acid Are Biomolecules and their Atoms Can Be Visualized by Two Different Ways 1) Fischer projections: Two dimensional representation of
BROILER. Nutrition Specifications. An Aviagen Brand
BROILER 708 Nutrition Specifications 2014 An Aviagen Brand Introduction Nutrition specifications for Ross 708 broilers are given in the following tables for a range of production and market situations
(a) (i) Describe how the production and action of interferon differs from the production and action of lysozyme. (3)
1 Histamine and the proteins interferon and lysozyme are involved in the non-specific responses to infection. (a) (i) escribe how the production and action of interferon differs from the production and
GSS resistant intermediate resistant susceptible NRTI - NtRTI NNRTI etravirine PI PI/r EI INI dolutegravir
KU Leuven Rega Institute for Medical Research and University Hospitals Leuven Microbiology and Immunology Clinical and Epidemiological Virology Ricardo Camacho, 3, Kristel Van Laethem, 2, Anna Maria Geretti
EFFECT OF SOME AMINO ACIDS ON THE GROWTH AND L-GLUTAMIC ACID FERMENTATION BY AN AUXOTROPHIC MUTANT Micrococcus glutamicus AB 100.
S. Ganguly et. al. / International Journal on Pharmaceutical and Biomedical Research (IJPBR) Vol. 2(1), 2011, 21-25 EFFECT OF SOME AMINO ACIDS ON THE GROWTH AND L-GLUTAMIC ACID FERMENTATION BY AN AUXOTROPHIC
Broiler Nutrition Specifications
Broiler Nutrition Specifications 2 Introduction 3 Table 1: Nutrition Specifications for As-Hatched Broilers - Target Live Weight
AAFCO Proficiency Testing Program: 2016 Participation
AAFCO Proficiency Testing Program: 206 Participation Lamb Feed, Medicated Swine Feed, Medicated 20632 2063 Poultry/Game Bird Feed Dairy Beef Feed Cattle Mineral Molasses Product, Dehydrated Cat Food, Dry
Thin-Layer Chromatography of Amino Acids HASPI Medical Biology Lab 15b Background Macromolecules
Thin-Layer Chromatography of s HASPI Medical Biology Lab 15b Background Macromolecules Name: Period: Date: There are four major types of biological macromolecules that make up the human body: nucleic acids
LIST OF FORMULATION PRODUCTS. Ferrocid Transule Capsule. Blended Pellets of Carbonyl Iron, Folic Acid & Zinc. Nature Biochem
LIST OF FORMULATION PRODUCTS Haematinics Ferrocid Transule Capsule Dried Ferrous Sulphate B.P. 1 Folic Acid B.P. 0.5 mg Eleron-F Dried Ferrous Sulphate I.P. 1 5 mg Cyanocobalamin I.P. 15 mcg Zinc Sulphate
R. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, J. L. Nelssen, S. S. Dritz 2, C. W. Hastad, K. R. Lawrence, and D. A.
Swine Day 2004 DETERMINATION OF THE APPARENT AND TRUE ILEAL AMINO ACID DIGESTIBILITY AND DIGESTIBLE AND METABOLIZABLE ENERGY OF SPECIALTY PROTEIN SOURCES INTENDED FOR NURSERY PIG DIETS 1 R. O. Gottlob,
COMMISSION REGULATION (EC)
14.10.2009 Official Journal of the European Union L 269/9 COMMISSION REGULATION (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional in foods for particular nutritional
MSUD HCU Tyrosinaemia MMA/PA GA gel (for PKU gel see pages 7-10)
MSUD HCU Tyrosinaemia MMA/PA GA el (for PKU el see paes 7-10) Description A food for special medical purposes. Unflavoured powdered protein substitutes containin essential and non-essential amino acids
DYMATIZE ELITE 100% WHEY The perfect anytime protein
DYMATIZE ELITE 100% WHEY The perfect anytime protein Product description The perfect anytime protein! Are you looking for an anytime protein with great value? Whether you re supporting muscle growth after
PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes
PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully. It provides a summary of information about your medicine.
SGS Germany GmbH Rödingsmarkt 16 D Hamburg t f
SGS Germany GmbH Rödingsmarkt 16 20459 Hamburg Company Alfa Laval Copenhagen A/S Maskinvej 5 2860 SOEBORG DÄNEMARK Test Report 2589950 Order No. 3404715 Customer No. 10043639 Larissa Münzberg Phone +49
Metabolism of Amino Acids in Aquatic Animals II
Mem. Fac. Fish., Kagoshima Univ. Vol. 26 pp. 45-48 (1977) Metabolism of Amino Acids in Aquatic Animals II The effect of an amino acid supplemented casein diet on the growth rate of carp Yoshito Tanaka,
SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DUPHALYTE Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Composition per ml VITAMINS
Proteins consist in whole or large part of amino acids. Simple proteins consist only of amino acids.
Today we begin our discussion of the structure and properties of proteins. Proteins consist in whole or large part of amino acids. Simple proteins consist only of amino acids. Conjugated proteins contain
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761
GOVERNMENT GAZETTE OF THE REPUBLIC OF N$4.00 WINDHOEK - 26 July 2011 No. 4761 CONTENTS Page GOVERNMENT NOTICE No. 122 Registration of certain medicines: Medicines and Related Substances Control Act, 2003...
BODY CHEMISTRY TEST. Sample Report
BODY CHEMISTRY TEST * Sample Report Ver. 1.0, Date created: Nov 5, 2017 Disclaimer: VitaminLab is for informational purposes only. lease discuss your results or concerns with your health care professional
PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes
PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex peri Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully before you start using this medicine because it contains
SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% Amino Acid Intravenous Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Leucine Ph. Eur 0.620% w/v L-Isoleucine
Official Journal of the European Communities
L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION
Ranger Gold. Parent Stock NUTRITION SPECIFICATIONS
Ranger Gold Parent Stock NUTRITION SPECIFICATIONS Introduction This booklet contains the nutritional recommendations for Ranger Gold parent stock and is to be used with the Parent Stock Management Handbook
SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PRIMENE 10% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each litre of the infusion solution contains: L-Isoleucine L-Leucine L-Valine
Product Category: EleCare
EleCare Product Category: EleCare EleCare (for Infants) Updated 4/28/2016 Product Information: EleCare (for Infants) 1 of 4 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who
Product Information: EleCare (for Infants)
1 of 5 Product Information: 2 of 5 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who cannot tolerate intact or hydrolyzed protein. EleCare is indicated for the dietary management
Detox Suite. A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms.
Detox Suite A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms. Features/Use I 3 d Liver Rx Liver Balance DPO FUNCTIONAL
ROSS 308 AP. Nutrition Specifications PARENT STOCK. An Aviagen Brand
1 PARENT STOCK ROSS 308 AP Nutrition Specifications An Aviagen Brand Introduction This booklet contains the nutritional recommendations for Ross 308 AP (slow feathering) parent stock and is to be used
Objective: You will be able to explain how the subcomponents of
Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:
SEQUENTIAL CULTURE MEDIA SYSTEM
SEQUENTIAL CULTURE MEDIA SYSTEM Gamete solutions... 7 Fertilization solutions...15 Cleavage solutions...21 Blastocyst solutions...27 STIC Media Stopper Removal Tool...35 Complete list of order numbers...36
Package leaflet: Information for the user. Kabiven, emulsion for infusion
Package leaflet: Information for the user, emulsion for infusion Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet.
Public Assessment Report Scientific discussion. Numeta G16E and Numeta G19E
Public Assessment Report Scientific discussion Numeta G16E and Numeta G19E Active substances: alanine, arginine, aspartic acid, cysteine, glucose, glutamic acid, glycine, histidine, isoleucine, leucine,
reductions Untangling the web of price reductions: eligibility pricecountries company price countries price
company price countries reductions pricecountries price eligibility reductions Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries 1st December 2003
The Global Health Impact Index
The Global Health Impact Index Ranking Explanation Reference Table Drug Abbreviation Drug Name 1. AL 1. Artemether-Lumefantrine 2. AS+AQ 2. Artesunate + Amodiaquine 3. AS+MQ 3. Artesunate + Mefloquine
A COMPARISON OF WHEY PROTEIN CONCENTRATE AND SPRAY-DRIED ANIMAL PLASMA IN DIETS FOR WEANLING PIGS 1
Swine Day 2004 A COMPARISON OF WHEY PROTEIN CONCENTRATE AND SPRAY-DRIED ANIMAL PLASMA IN DIETS FOR WEANLING PIGS 1 R. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, S. S. Dritz 2, J. L. Nelssen,
What Are Proteins? Lecture 9: Proteins. Proteins: large complex molecules composed of amino acids. Nutrition 150 Shallin Busch, Ph.D.
What Are Proteins? Lecture 9: Proteins Nutrition 150 Shallin Busch, Ph.D. Proteins: large complex molecules composed of amino acids. Contain carbon, hydrogen, oxygen, nitrogen Primary source of nitrogen
So where were we? But what does the order mean? OK, so what's a protein? 4/1/11
So where were we? We know that DNA is responsible for heredity Chromosomes are long pieces of DNA DNA turned out to be the transforming principle We know that DNA is shaped like a long double helix, with
PROTEIN. By: Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology UPM
PROTEIN By: Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology UPM OBJECTIVES OF THE LECTURE By the end of this lecture, student can: Define
reductions Untangling the web of price reductions: 6th Edition eligibility pricecountries company price countries price
company price countries reductions pricecountries price eligibility reductions Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries 6th Edition 19th
Amino acids. (Foundation Block) Dr. Essa Sabi
Amino acids (Foundation Block) Dr. Essa Sabi Learning outcomes What are the amino acids? General structure. Classification of amino acids. Optical properties. Amino acid configuration. Non-standard amino
M1 - Renal, Fall 2007
University of Michigan Deep Blue deepblue.lib.umich.edu 2007-09 M1 - Renal, Fall 2007 Lyons, R.; Burney, R. Lyons, R., Burney, R. (2008, August 07). Renal. Retrieved from Open.Michigan - Educational Resources
Cornstarch
Electronic Supplementary Material (ESI) for Food & Function. This journal is The Royal Society of Chemistry 2018 Supplementary data : Supplementary Table 1: Diet composition (g/kg) on the basis of the
What is ProPound Canola Meal?
A New, Cost Effective Protein Replacement for Meal in Swine Diets What is Canola Meal? PROTEIN CONTENT ingredient pricing scenarios and in a variety of swine 1500 is less than that of soybean meal, resulting